Optimizing Anesthesia for Post Partum Tubal Ligations

• Status: Terminated
• Trial end date: 2020-12-03
• Target enrollment: 0
• Participant gender: Female

Summary

In this study, the investigators will compare CLOROTEKAL® (1% spinal chloroprocaine) to low-dose isobaric bupivacaine using the epidural volume extension (EVE) technique in patients undergoing post-partum tubal ligation (PPBTL). This will be a randomized, double-blinded study. Patients scheduled for PPBTL at the Women and Infants Center (WIC) will be eligible for enrollment in this study. Outcomes measured will include: ability to achieve an adequate level required for surgery (T6), rate of epidural activation, and duration of the block. The investigators hope to determine the usefulness of each drug using the EVE technique in the setting of PPBTL.

• Phase: Phase 2
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Alabama at Birmingham
• Treatments: Bupivacaine; Chloroprocaine; Procaine

Criteria

Inclusion Criteria:

• Any patient scheduled for a postpartum tubal ligation at the Women and Infants Center will be eligible for the study

Exclusion Criteria:

• age less than 18 years old

• allergy to either local anesthetic class (amide or ester)

• contraindication to spinal anesthesia